Total Payments
$1,447
2024 Payments
$282.91
Companies
14
Transactions
68
Medicare Patients
263
Medicare Billing
$47,748

Payment Breakdown by Category

Food & Beverage$1,427 (98.6%)
Education$20.00 (1.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,427 67 98.6%
Education $20.00 1 1.4%

Top Paying Companies

Company Total Records Latest Year
GlaxoSmithKline, LLC. $602.84 27 $0 (2024)
Genentech USA, Inc. $229.90 14 $0 (2023)
AstraZeneca Pharmaceuticals LP $152.12 8 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $81.99 3 $0 (2023)
Amgen Inc. $78.87 3 $0 (2024)
Inari Medical, Inc. $67.66 1 $0 (2023)
CSL Behring $47.66 2 $0 (2024)
Regeneron Healthcare Solutions, Inc. $43.12 2 $0 (2021)
Chiesi USA, Inc. $31.93 2 $0 (2023)
BOSTON SCIENTIFIC CORPORATION $30.01 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $282.91 11 GlaxoSmithKline, LLC. ($126.49)
2023 $288.41 11 Inari Medical, Inc. ($67.66)
2022 $205.07 12 Genentech USA, Inc. ($72.23)
2021 $82.65 4 GlaxoSmithKline, LLC. ($27.50)
2020 $127.69 5 GlaxoSmithKline, LLC. ($84.63)
2019 $375.62 21 GlaxoSmithKline, LLC. ($245.31)
2018 $84.27 4 GlaxoSmithKline, LLC. ($65.97)

All Payment Transactions

68 individual payment records from CMS Open Payments — Page 2 of 3

Date Company Product Nature Form Amount Type
06/30/2022 Shionogi Inc Fetroja (Drug) Food and Beverage In-kind items and services $13.03 General
Category: Infections and Infectious Diseases
05/27/2022 Chiesi USA, Inc. CLEVIPREX (Drug) Food and Beverage Cash or cash equivalent $18.54 General
Category: CARDIOVASCULAR
05/26/2022 Genentech USA, Inc. Food and Beverage In-kind items and services $19.09 General
04/29/2022 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $23.16 General
Category: Respiratory
03/11/2022 Genentech USA, Inc. Xolair (Biological), Actemra, Esbriet Food and Beverage In-kind items and services $6.66 General
Category: Immunology
03/11/2022 Genentech USA, Inc. Xolair (Biological), Actemra, Esbriet Food and Beverage In-kind items and services $5.58 General
Category: Immunology
02/03/2022 BOSTON SCIENTIFIC CORPORATION General - Vascular Access (Device) Food and Beverage Cash or cash equivalent $30.01 General
Category: THROMBECTOMY
01/28/2022 Genentech USA, Inc. Xolair (Biological), Actemra, Activase Food and Beverage In-kind items and services $21.26 General
Category: Immunology
01/28/2022 Genentech USA, Inc. Xolair (Biological), Actemra, Activase Food and Beverage In-kind items and services $0.85 General
Category: Immunology
12/08/2021 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $16.12 General
Category: INFLAMMATION AND IMMUNOLOGY
12/03/2021 Genentech USA, Inc. Food and Beverage In-kind items and services $24.11 General
07/29/2021 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $27.50 General
Category: IMMUNOLOGY
02/12/2021 Gilead Sciences, Inc. Food and Beverage In-kind items and services $14.92 General
10/15/2020 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $32.72 General
Category: RESPIRATORY
03/06/2020 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $34.18 General
Category: RESPIRATORY
02/21/2020 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Food and Beverage In-kind items and services $22.36 General
Category: RESPIRATORY
02/21/2020 AstraZeneca Pharmaceuticals LP FASENRA (Drug) Food and Beverage In-kind items and services $20.70 General
Category: Respiratory
02/17/2020 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $17.73 General
Category: RESPIRATORY
12/20/2019 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $32.57 General
Category: RESPIRATORY
11/22/2019 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $16.94 General
Category: RESPIRATORY
11/15/2019 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $8.02 General
Category: RESPIRATORY
10/25/2019 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $16.80 General
Category: RESPIRATORY
10/22/2019 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $12.73 General
Category: RESPIRATORY
10/11/2019 Genentech USA, Inc. Xolair (Biological) Food and Beverage In-kind items and services $13.36 General
Category: Immunology
10/04/2019 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $15.54 General
Category: RESPIRATORY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 57 95 $38,544 $11,980
2022 3 63 89 $27,144 $8,890
2021 3 66 101 $37,895 $13,210
2020 4 77 126 $43,007 $13,667
Total Patients
263
Total Services
411
Medicare Billing
$47,748
Procedure Codes
13

All Medicare Procedures & Services

13 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99291 Critical care, first 30-74 minutes Facility 2023 25 38 $23,826 $7,526 31.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 21 30 $8,508 $2,450 28.8%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 11 27 $6,210 $2,005 32.3%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 26 46 $9,614 $3,147 32.7%
99291 Critical care, first 30-74 minutes Facility 2022 13 14 $9,142 $3,146 34.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 24 29 $8,388 $2,597 31.0%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2021 14 24 $15,200 $5,693 37.5%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 24 42 $12,450 $4,406 35.4%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 28 35 $10,245 $3,111 30.4%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 22 53 $16,212 $5,459 33.7%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2020 15 24 $15,888 $5,017 31.6%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 23 25 $5,819 $1,613 27.7%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 17 24 $5,088 $1,578 31.0%

About Dr. Elie Hatem, M.D

Dr. Elie Hatem, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Staten Island, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/09/2008. The National Provider Identifier (NPI) number assigned to this provider is 1215172929.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elie Hatem, M.D has received a total of $1,447 in payments from pharmaceutical and medical device companies, with $282.91 received in 2024. These payments were reported across 68 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,427).

As a Medicare-enrolled provider, Hatem has provided services to 263 Medicare beneficiaries, totaling 411 services with total Medicare billing of $47,748. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.

Practice Information

Products in Payments

  • NUCALA (Biological) $570.04
  • Xolair (Biological) $167.91
  • TEZSPIRE (Biological) $93.69
  • FASENRA (Biological) $82.93
  • OFEV (Drug) $81.99
  • FLOWTRIEVER CATHETER, S (Device) $67.66
  • DUPIXENT (Biological) $62.24
  • FASENRA (Drug) $54.37
  • Kcentra (Biological) $47.66
  • CLEVIPREX (Drug) $31.93
  • General - Vascular Access (Device) $30.01
  • Fetroja (Drug) $28.18
  • GIAPREZA (Drug) $18.30
  • ANORO (Drug) $17.26
  • TRELEGY ELLIPTA (Drug) $15.54

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Staten Island